Grace Therapeutics, Inc. (GRCE)
SG&A Expenses
$1.69M
Quarterly · Period ending: · USD
GRCE SG&A Expenses
Latest reported$1.69Mperiod ending
Latest reported$1.69Mperiod ending
GRCE Quarterly SG&A Expenses ($96.87K → $1.69M)
Quarterly SG&A Expenses
High-resolution chart · PNG
GRCE sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 1,687,000 | |
| 308,589 | |
| 2,723,678 | |
| 2,733,670 | |
| 2,133,000 | |
| 2,203,098 | |
| 2,170,077 | |
| 1,853,000 | |
| 3,082,638 | |
| 2,093,866 | |
| 2,120,788 | |
| 2,208,749 | |
| 2,478,632 | |
| 3,402,969 | |
| 2,384,966 | |
| 1,828,000 | |
| 2,696,175 | |
| 2,595,156 | |
| 2,607,594 | |
| 3,778,442 | |
| 4,093,022 | |
| 2,381,436 | |
| 2,170,092 | |
| 2,572,547 | |
| 4,350,246 | |
| 3,746,631 | |
| 2,234,000 | |
| 2,301,000 | |
| 1,816,000 | |
| 1,668,622 | |
| 847,264 | |
| 1,013,924 | |
| 787,712 | |
| 956,865 | |
| 687,872 | |
| 835,126 | |
| 628,190 | |
| 617,026 | |
| 653,899 | |
| 433,962 | |
| -1,038,757 | |
| 359,728 | |
| 379,633 | |
| 507,967 | |
| 655,553 | |
| 1,065,886 | |
| 1,522,389 | |
| 1,642,117 | |
| 1,230,074 | |
| 1,927,854 | |
| 1,752,868 | |
| 1,167,616 | |
| 965,802 | |
| 1,045,963 | |
| 1,101,836 | |
| 1,037,019 | |
| 1,259,033 | |
| 823,528 | |
| 873,593 | |
| 655,882 | |
| 291,499 | |
| 424,789 | |
| 320,498 | |
| 278,730 | |
| 146,999 | |
| 97,555 | |
| 97,485 | |
| 61,218 | |
| 96,873 |